
NEU
Neuren Pharmaceuticals
Pharmaceuticals, Biotechnology & Life Sciences
Neuren Pharmaceuticals is a biopharmaceutical company focused on developing therapies for neurological conditions. The company is positioned in the biotechnology sector, leveraging its expertise in neuroscience to address unmet medical needs. Neuren's unique value lies in its targeted approach to treating rare neurological disorders, with a strong pipeline of innovative products.
biopharmaceuticals
neurological conditions
ASX
biotechnology
Shorted
short percentage5.47%
reported shorts6.9M
shares on issue126.640M